 | Up a level |
Clemens, Eva; van den Heuvel-Eibrink, Marry M; Mulder, Renée L; Kremer, Leontien C M; Hudson, Melissa M; Skinner, Roderick; Constine, Louis S; Bass, Johnnie K; Kuehni, Claudia E; Langer, Thorsten; van Dalen, Elvira C; Bardi, Edith; Bonne, Nicolas-Xavier; Brock, Penelope R; Brooks, Beth; Carleton, Bruce; Caron, Eric; Chang, Kay W; Johnston, Karen; Knight, Kristin; ... (2019). Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium. Lancet oncology, 20(1), e29-e41. Elsevier 10.1016/S1470-2045(18)30858-1
Drögemöller, Britt I; Monzon, Jose G; Bhavsar, Amit P; Borrie, Adrienne E; Brooks, Beth; Wright, Galen E B; Liu, Geoffrey; Renouf, Daniel J; Kollmannsberger, Christian K; Bedard, Philippe L; Aminkeng, Folefac; Amstutz, Ursula; Hildebrand, Claudette A; Gunaretnam, Erandika P; Critchley, Carol; Chen, Zhuo; Brunham, Liam R; Hayden, Michael R; Ross, Colin J D; Gelmon, Karen A; ... (2017). Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer. JAMA oncology, 3(11), pp. 1558-1562. American Medical Association 10.1001/jamaoncol.2017.0502
